DHT and GLP-1 Medicines: What We Know About Hair Loss (October 2026)

01 · The core answer

Is DHT relevant if you take a GLP-1 medicine?

DHT is relevant mainly if your hair loss follows a pattern: a receding hairline, thinning at the temples or crown, or a parting that keeps widening. That pattern is typical of inherited androgenetic alopecia, which is driven by how your hair follicles respond to DHT. It usually develops over a long time and can run in families.

Diffuse thinning looks different. Hair comes out across the whole scalp, often in the shower or on a brush, and it tends to appear some weeks after a big change such as a major diet shift. That is a shedding process, not a DHT process. Many people on weight-loss treatment experience this second type, but only an assessment can tell you which you have.

Hair loss is a listed side effect of Mounjaro in the UK patient leaflet (common, up to 1 in 10 people), and temporary hair shedding is linked to rapid weight loss itself rather than a direct drug effect. Nothing establishes that tirzepatide changes DHT levels or causes pattern hair loss.

The most useful distinction for you is practical. Look at where and how the hair is thinning, note when it started relative to your treatment, and take that to a prescriber. Our guide to DHT, GLP-1 and hair loss goes deeper on the patterns, and the page on DHT and Mounjaro covers tirzepatide specifically.

02 · Your next step

What should you do if your hair is thinning on treatment?

Start by telling the prescriber who reviews your treatment. Ongoing monthly reviews are part of care with us, and side-effect support is included, so a change in your hair is a legitimate thing to raise. A prescriber can ask about your diet, your pace of weight change, your family history and other health factors.

Check the side-effects section of the patient information leaflet in your pack, and read it alongside your prescriber's advice. If you notice anything new that worries you, you can also report it through the Yellow Card scheme.¹⁹ Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.

If your hair thinning looks like inherited pattern loss, a GP or a pharmacist can discuss options. Do not buy hormone-altering products online or begin a DHT blocker without advice, especially while you are changing your medicines. If you are still weighing up treatment, our weight loss clinic explains how a consultation works.

Related guides: Rowe glp1 and Pmos glp1 and Is trizepatide a glp1.

03 · What DHT is

What is DHT and what does it do to hair?

DHT, short for dihydrotestosterone, is an androgen hormone made in the body from testosterone. It is present in men and women, though typically at different levels. In people who inherit sensitive hair follicles, DHT is thought to shrink those follicles gradually, so each growth cycle produces a finer, shorter hair.

This is why pattern hair loss is often described as genetic. The hormone level itself may be ordinary. What differs is how your follicles react to it. Two people with similar hormone levels can have very different hair outcomes.

Because it develops slowly, pattern loss rarely appears overnight. You are more likely to notice that your hairline has moved over a long period, or that your parting looks wider than it used to. That timing is a useful clue when you are trying to work out whether a recent medicine started the problem or simply coincided with it.

DHT-related thinning can begin at different life stages, and there is no single age at which hair is thickest or DHT is highest that applies to everyone. If your thinning is a concern, a clinician can assess your own pattern rather than relying on an average.

04 · Shedding versus pattern loss

How is temporary shedding different from DHT hair loss?

Temporary shedding, usually called telogen effluvium, happens when a larger share of hairs move into the resting and shedding phase together. It is typically triggered by a stressor on the body, such as illness, a hormonal shift, or a rapid change in eating. It is diffuse, meaning it affects the whole scalp rather than one zone.

DHT pattern loss is localised and progressive. It follows a recognisable map: the front and temples in many men, the crown, and a widening central parting in many women. It does not usually reverse by itself.

People can have both at once. Someone with an inherited tendency might find a shedding episode brings the underlying pattern into view sooner. That overlap is part of why the question of DHT and GLP-1 medicines is hard to answer cleanly.

Mounjaro is used alongside a reduced-calorie diet and increased physical activity, and weight loss on Mounjaro is gradual by design. A big change in eating is a recognised kind of trigger for shedding in general, which is one reason prescribers ask about diet when hair is a concern.

05 · What research says

What does the research say about GLP-1 medicines and DHT?

Some recent academic work has looked at whether people with a genetic tendency towards higher GLP-1 receptor activity have a modestly higher chance of pattern hair loss. Headlines about this have circulated widely.

Genetic association studies look at inherited variation across populations. They can suggest a link, but they do not show that taking a medicine causes a particular outcome in an individual. They also cannot tell you what will happen to your hair.

The mechanism is also still being explored. Researchers do not yet agree on exactly how, or whether, GLP-1 signalling relates to hair follicles. Until that is clearer, a link to pattern hair loss is possible but unproven, and most people who notice shedding during weight loss are more likely seeing a temporary process.

The trial evidence for tirzepatide is about weight. In SURMOUNT-1, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone. These are trial averages, and individual results vary.² That tells you about the scale of change the body may go through, not about hair.

06 · Signs and tests

How can you tell if DHT is causing your hair loss?

The best clues are the location, the speed and the family history. A receding hairline, thinning at the crown, or a parting that slowly widens, especially if a parent or grandparent had similar changes, points towards DHT-driven pattern loss. Diffuse shedding that began within a few weeks or months of a major change points elsewhere.

You may also see hairs becoming finer and shorter over time, and a scalp that shows through more under bright light. Hair that is simply coming out in larger amounts, with normal thickness on each strand, fits shedding better.

Blood levels of DHT are not a reliable way to diagnose pattern hair loss, because the issue is usually follicle sensitivity rather than the amount of hormone. If you also notice other changes, such as irregular periods, excess facial or body hair or acne, mention these. They can relate to hormone conditions that a doctor should assess.

A GP or dermatology service can examine your scalp, review your history and, if needed, arrange blood tests for common contributors such as iron or thyroid problems. That is a better route than guessing from online checklists.

07 · Regrowth and blocking DHT

Can hair loss grow back, and why not simply block DHT?

It depends on the cause. Temporary shedding often settles once the trigger passes, and hair frequently regrows. Pattern loss is different: follicles that have shrunk over a long time may not fully recover, and treatment is usually about slowing progression and encouraging what remains.

Blocking DHT is not a casual choice. Medicines that reduce DHT act on hormone pathways, and they carry their own considerations that depend on your sex, age and health. They are prescription or pharmacist-supervised options for good reason. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Women who are pregnant or may become pregnant also need specific advice before using any hormone-altering hair treatment.

Natural products are not a replacement for assessment, and dosing is not standardised. A low-cost supplement with no clinical oversight is unlikely to be a reliable answer to a hormone-driven process.

Ask a GP, pharmacist or dermatologist which options suit you, and whether they interact with any medicine you take. If you take Mounjaro, tell them so they can check the full picture.

08 · Looking after hair on treatment

How can you look after your hair while losing weight?

Focus on what you can control and keep your prescriber informed. Mounjaro is used alongside a reduced-calorie diet and increased physical activity.¹ A reduced-calorie diet should still be a balanced one. Eating very little, or skipping whole food groups, is not what treatment is designed for.

Tirzepatide activates the GIP and GLP-1 receptors, helping regulate appetite and slow how quickly the stomach empties, so most people feel fuller sooner and less hungry between meals.¹ That fullness can make it easy to under-eat without noticing. If meals are getting very small, say so at your review. Your prescriber can discuss pacing and whether your dose is right for you.

Other practical steps include being gentle with your hair, avoiding tight hairstyles and harsh heat, and not making several big lifestyle changes at once. If something else changed at the same time, such as illness, stress or a new medicine, mention it. These details help a clinician work out the real cause.

If you stop treatment, Mounjaro takes roughly four to five weeks to clear the system, and there is no way to speed this up.¹ Do not stop on your own because of hair changes without speaking to your prescriber. You may be able to adjust your approach rather than abandon something that is otherwise working. You can report suspected side effects through the MHRA Yellow Card scheme.¹⁹

09 · Mounjaro and other GLP-1s

Does the question differ for Mounjaro, Wegovy and others?

Hair outcomes are not a basis for ranking these medicines. Tirzepatide is the first treatment of its kind to activate two receptors at once, GIP and GLP-1, which distinguishes it from single-action medicines such as semaglutide.¹

If you are deciding between treatments, hair should be one consideration among many, alongside suitability, how well you tolerate the medicine and cost. You can also see the Wegovy pen if you want to compare products.